BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 27486922)

  • 1. Prison officers' views about hepatitis C testing and treatment: a qualitative enquiry.
    Jack K; Islip N; Linsley P; Thomson B; Patterson A
    J Clin Nurs; 2017 Jul; 26(13-14):1861-1868. PubMed ID: 27486922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel.
    Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C;
    Int J Drug Policy; 2021 Dec; 98():103379. PubMed ID: 34311138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do people in prison feel about opt-out hepatitis C virus testing?
    Jack K; Linsley P; Thomson BJ; Irving WL
    J Viral Hepat; 2020 Oct; 27(10):1003-1011. PubMed ID: 32488916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an e-learning package to improve understanding of blood-borne viruses amongst prison staff in Wales, UK.
    Ellen Perrett S; Erricker M; Lyons M
    Int J Prison Health; 2014; 10(1):47-54. PubMed ID: 25763984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.
    Crowley D; Van Hout MC; Murphy C; Kelly E; Lambert JS; Cullen W
    Health Justice; 2018 Dec; 6(1):23. PubMed ID: 30569249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.
    Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C;
    Int J Drug Policy; 2022 Aug; 106():103746. PubMed ID: 35636069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prison officers' attitudes towards self-harm in prisoners.
    Sousa M; Gonçalves RA; Cruz AR; de Castro Rodrigues A
    Int J Law Psychiatry; 2019; 66():101490. PubMed ID: 31706411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bowel cancer screening in an English prison: a qualitative service evaluation.
    Blagden S; Simpson C; Limmer M
    Public Health; 2020 Mar; 180():46-50. PubMed ID: 31855618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
    Rance J; Lafferty L; Treloar C;
    Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical exploration of the management of self-harm in a male custodial setting: qualitative findings of a comparative analysis of prison staff views on self-harm.
    Ramluggun P
    J Forensic Nurs; 2013; 9(1):23-34. PubMed ID: 24158098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting.
    Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C
    Addiction; 2021 May; 116(5):1162-1171. PubMed ID: 33006784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing for hepatitis C virus infection in UK prisons: What actually happens?
    Jack K; Thomson BJ; Irving WL
    J Viral Hepat; 2019 Jun; 26(6):644-654. PubMed ID: 30702194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners.
    Khaw FM; Stobbart L; Murtagh MJ
    BMC Public Health; 2007 Jun; 7():98. PubMed ID: 17555573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C in Australian prisons: a national needs assessment.
    Mina MM; Herawati L; Butler T; Lloyd A
    Int J Prison Health; 2016; 12(1):3-16. PubMed ID: 26933988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety and styles of coping with occupational stress resulting from work with 'dangerous' prisoners in prison service officers.
    Tsirigotis K; Gruszczyński W; Pęczkowski S
    Acta Neuropsychiatr; 2015 Oct; 27(5):297-306. PubMed ID: 26022450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.
    Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C
    Addiction; 2023 Jun; 118(6):1153-1160. PubMed ID: 36683132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing blood borne virus services across prisons in Wales, UK.
    Perrett SE; Craine N; Lyons M
    Int J Prison Health; 2013; 9(1):31-9. PubMed ID: 25758321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges for prison governors and staff in implementing the Healthy Prisons Agenda in English prisons.
    Ismail N; de Viggiani N
    Public Health; 2018 Sep; 162():91-97. PubMed ID: 29990617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
    Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
    Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs and discretionary power in prisons: The officer's perspective.
    Kolind T
    Int J Drug Policy; 2015 Sep; 26(9):799-807. PubMed ID: 26005039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.